Align Technology vs Haemonetics
Align Technology (ALGN) and Haemonetics (HAE) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $10.9B
- Last close
- $155.17
- 12 months
- +16.8%
- Market value
- $5.47B
- Last close
- $120.16
- 12 months
- +60.0%
At a glance
- The biggest part of Align Technology's revenue is Clear Aligner (80%); at Haemonetics it is Hospital (44%).
- Align Technology earns 41% of its revenue in the United States, Haemonetics 74%.
- By market value, Align Technology ($10.9B) is about 2.0 times Haemonetics ($5.5B).
- Over the last 12 months Align Technology's share price moved +16.8% and Haemonetics's +60.0%; against the S&P 500 that is +11.1 points and +54.2 points.
- In their last fiscal years Align Technology kept 10.2% of revenue as net income and Haemonetics 7.3%.
- In the last 90 days insiders reported 0 open-market purchases at Align Technology and 0 at Haemonetics; members of Congress disclosed 0 trades in Align Technology and 0 in Haemonetics.
- Next results: Align Technology Feb 3, 2027, Haemonetics Feb 3, 2027.
How each one makes money: Align Technology revenue · Haemonetics revenue
Share prices on one chart
Align Technology and Haemonetics, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Align Technology ALGNNASDAQ · Health Care Supplies | Haemonetics HAENYSE · Health Care Supplies | |
|---|---|---|
| Size and profitability | ||
| Market value | $10.9B | $5.47B |
| Revenue, last fiscal year | $4.03B | $1.33B |
| Net income, last fiscal year | $410M | $97.3M |
| Net marginNet income as a share of revenue | 10.2% | 7.3% |
| Free cash flow | $491M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Align Technology against
Common questions
How is Align Technology different from Haemonetics?
Align Technology (ALGN) is in Health Care Supplies on NASDAQ, with $4.03B of revenue in its last fiscal year and a net margin of 10.2%. Haemonetics (HAE) is in Health Care Supplies on NYSE, with $1.33B of revenue in its last fiscal year and a net margin of 7.3%. The biggest part of Align Technology's revenue is Clear Aligner (80%); at Haemonetics it is Hospital (44%). Align Technology earns 41% of its revenue in the United States, Haemonetics 74%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Align Technology and Haemonetics compare in size?
Align Technology has the larger market value: Align Technology $10.9B and Haemonetics $5.47B, at the last close.
Whose share price rose more over the last 12 months, ALGN or HAE?
Over the last 12 months Align Technology moved +16.8% and Haemonetics +60.0%. Past price moves say nothing about the future.
Which has had more insider buying, Align Technology or Haemonetics?
Since 2006, Haemonetics insiders reported 142 open-market purchases against 59 for Align Technology. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ALGN or HAE?
In the last 12 months, members of Congress disclosed 0 trades in Align Technology (ALGN) and 0 in Haemonetics (HAE).
When did insiders last buy ALGN and HAE?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Align Technology pageHaemonetics pageRare insider trades this weekAll comparisons
https://oqro.io/compare/algn-vs-hae



